Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 18;10(10):2173.
doi: 10.3390/jcm10102173.

Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study

Affiliations

Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study

Łukasz Rzepiński et al. J Clin Med. .

Abstract

This study assessed cardiac autonomic response to head-up tilt test (HUTT) in 23 myasthenia gravis (MG) and 23 relapsing-remitting multiple sclerosis (RRMS) patients compared to 30 healthy controls (HC). Task Force® Monitor was used to evaluate cardiac inotropy parameters, baroreflex sensitivity (BRS), heart rate (HRV), and blood pressure variability (BPV) during HUTT. MG patients were characterized by reduced BRS (p < 0.05), post-HUTT decrease in high-frequency component (p < 0.05) and increase in sympathovagal ratio of HRV (p < 0.05) when compared to controls indicating parasympathetic deficiency with a shift of sympathovagal balance toward sympathetic predominance. Compared to HC, MG patients also showed lower cardiac inotropy parameters, specifically, left ventricular work index (LVWI) during supine rest (p < 0.05) as well as LVWI and cardiac index values in response to orthostatic stress (p < 0.01 and p < 0.05, respectively). Compared to controls, RRMS patients were characterized by lower HRV delta power spectral density (p < 0.05) and delta low-frequency HRV (p < 0.05) in response to HUTT suggesting combined sympathetic and parasympathetic dysfunction. There were no differences in cardiac autonomic parameters between MG and MS patients (p > 0.05). Our study highlights the possibility of cardiac and autonomic dysfunction in patients with MG and RRMS which should be considered in the pharmacological and rehabilitation approach to managing these conditions.

Keywords: blood pressure variability; cardiac autonomic dysfunction; heart rate variability; myasthenia gravis; relapsing-remitting multiple sclerosis; sympathovagal ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
MG, MS, and HC groups mean values (±SD) of CI, cardiac index (A); TFC, thoracic fluid content (B); LVWI, left ventricular work index (C); respectively for compared to healthy controls.
Figure 2
Figure 2
MS and MG groups mean values (±SD) of LFnu-RRI, low frequency R-R interval in normalised units (A); HFnu-RRI, high frequency R-R interval in normalised (B); PSD-RRI, power spectral density of heart rate variability (C); LF/HF-RRI, ratio between low and high band for heart rate variability (D); BRS, baroreflex sensitivity (E); respectively for compared to healthy controls.

Similar articles

Cited by

References

    1. Danikowski K.M., Jayaraman S., Prabhakar B.S. Regulatory T cells in multiple sclerosis and myasthenia gravis. J. Neuroinflamm. 2017;14:117. doi: 10.1186/s12974-017-0892-8. - DOI - PMC - PubMed
    1. Stüve O., Zettl U. Neuroinflammation of the central and peripheral nervous system: An update. Clin. Exp. Immunol. 2014;175:333–335. doi: 10.1111/cei.12260. - DOI - PMC - PubMed
    1. Gilhus N.E., Tzartos S., Evoli A., Palace J., Burns T.M., Verschuuren J.J.G.M. Myasthenia gravis. Nat. Rev. Dis. Primer. 2019;5:30. doi: 10.1038/s41572-019-0079-y. - DOI - PubMed
    1. Thompson A.J., Baranzini S.E., Geurts J., Hemmer B., Ciccarelli O. Multiple sclerosis. Lancet. 2018;391:1622–1636. doi: 10.1016/S0140-6736(18)30481-1. - DOI - PubMed
    1. Kataria H., Hart C.G., Alizadeh A., Cossoy M., Kaushik D.K., Bernstein C.N., Marrie R.A., Yong V.W., Karimi-Abdolrezaee S. Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis. Brain. 2021;12:162–185. doi: 10.1093/brain/awaa385. - DOI - PMC - PubMed

LinkOut - more resources